Phaselic acid, (-)-

Details

Top
Internal ID 54cfdf9b-f83e-4aa4-95b2-a2c386b79038
Taxonomy Phenylpropanoids and polyketides > Cinnamic acids and derivatives > Hydroxycinnamic acids and derivatives > Coumaric acids and derivatives
IUPAC Name (2R)-2-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxybutanedioic acid
SMILES (Canonical) C1=CC(=C(C=C1C=CC(=O)OC(CC(=O)O)C(=O)O)O)O
SMILES (Isomeric) C1=CC(=C(C=C1/C=C/C(=O)O[C@H](CC(=O)O)C(=O)O)O)O
InChI InChI=1S/C13H12O8/c14-8-3-1-7(5-9(8)15)2-4-12(18)21-10(13(19)20)6-11(16)17/h1-5,10,14-15H,6H2,(H,16,17)(H,19,20)/b4-2+/t10-/m1/s1
InChI Key PMKQSEYPLQIEAY-XCRNYIDWSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C13H12O8
Molecular Weight 296.23 g/mol
Exact Mass 296.05321734 g/mol
Topological Polar Surface Area (TPSA) 141.00 Ų
XlogP 0.60
Atomic LogP (AlogP) 0.58
H-Bond Acceptor 6
H-Bond Donor 4
Rotatable Bonds 6

Synonyms

Top
W3PJ394QLY
UNII-W3PJ394QLY
423170-79-0
(2R)-2-(((2E)-3-(3,4-Dihydroxyphenyl)-1-oxo-2-propen-1-yl)oxy)butanedioic acid
Butanedioic acid, (((2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-, (2R)-
Butanedioic acid, 2-(((2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl)oxy)-, (2R)-
(2R')-Phaselic acid
SCHEMBL21191515
(R)-2-(3,4-Dihydroxycinnamoyloxy)succinic acid

2D Structure

Top
2D Structure of Phaselic acid, (-)-

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9431 94.31%
Caco-2 - 0.8630 86.30%
Blood Brain Barrier - 0.5750 57.50%
Human oral bioavailability - 0.5714 57.14%
Subcellular localzation Mitochondria 0.7286 72.86%
OATP2B1 inhibitior - 0.7154 71.54%
OATP1B1 inhibitior + 0.9447 94.47%
OATP1B3 inhibitior + 0.9580 95.80%
MATE1 inhibitior + 0.5200 52.00%
OCT2 inhibitior - 0.9000 90.00%
BSEP inhibitior - 0.6518 65.18%
P-glycoprotein inhibitior - 0.9595 95.95%
P-glycoprotein substrate - 0.9547 95.47%
CYP3A4 substrate - 0.5935 59.35%
CYP2C9 substrate - 0.5979 59.79%
CYP2D6 substrate - 0.8612 86.12%
CYP3A4 inhibition - 0.9113 91.13%
CYP2C9 inhibition - 0.9697 96.97%
CYP2C19 inhibition - 0.9669 96.69%
CYP2D6 inhibition - 0.9476 94.76%
CYP1A2 inhibition - 0.9086 90.86%
CYP2C8 inhibition + 0.4603 46.03%
CYP inhibitory promiscuity - 0.9779 97.79%
UGT catelyzed + 0.7000 70.00%
Carcinogenicity (binary) - 0.8575 85.75%
Carcinogenicity (trinary) Non-required 0.6600 66.00%
Eye corrosion - 0.9477 94.77%
Eye irritation + 0.5540 55.40%
Skin irritation + 0.5109 51.09%
Skin corrosion - 0.8843 88.43%
Ames mutagenesis - 0.7300 73.00%
Human Ether-a-go-go-Related Gene inhibition - 0.7674 76.74%
Micronuclear + 0.8018 80.18%
Hepatotoxicity - 0.5875 58.75%
skin sensitisation + 0.7296 72.96%
Respiratory toxicity + 0.5111 51.11%
Reproductive toxicity + 0.7111 71.11%
Mitochondrial toxicity + 0.5500 55.00%
Nephrotoxicity - 0.8524 85.24%
Acute Oral Toxicity (c) III 0.7214 72.14%
Estrogen receptor binding + 0.6047 60.47%
Androgen receptor binding + 0.8555 85.55%
Thyroid receptor binding - 0.7392 73.92%
Glucocorticoid receptor binding - 0.4704 47.04%
Aromatase binding - 0.5829 58.29%
PPAR gamma - 0.5902 59.02%
Honey bee toxicity - 0.8586 85.86%
Biodegradation - 0.6250 62.50%
Crustacea aquatic toxicity - 0.6455 64.55%
Fish aquatic toxicity + 0.9618 96.18%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 99.30% 91.11%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 95.97% 96.00%
CHEMBL1860 P10827 Thyroid hormone receptor alpha 93.19% 99.15%
CHEMBL3194 P02766 Transthyretin 92.67% 90.71%
CHEMBL1293249 Q13887 Kruppel-like factor 5 92.53% 86.33%
CHEMBL3060 Q9Y345 Glycine transporter 2 91.62% 99.17%
CHEMBL2581 P07339 Cathepsin D 91.20% 98.95%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 89.04% 95.56%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 87.49% 96.09%
CHEMBL1951 P21397 Monoamine oxidase A 85.80% 91.49%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 85.09% 94.45%
CHEMBL1806 P11388 DNA topoisomerase II alpha 83.67% 89.00%
CHEMBL2035 P08912 Muscarinic acetylcholine receptor M5 82.24% 94.62%

Cross-Links

Top
PubChem 92299542
NPASS NPC157721
LOTUS LTS0169052
wikiData Q105211547